Vendor, Watertown, MA
Pathcision Medicine, Inc.
UEI CK6QRF2GLBT1, CAGE 9BD69
1 award and $299,981 obligated between August 5, 2025 and July 20, 2026, 100% under full and open competition, against 55.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $299,981 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Pathcision Medicine, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Pathcision Medicine, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $299,981
- Soonest
- February 10, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2025
National Institutes of Health, NIH NCI
SolicitationSmall businessNAICS 54171Massachusetts75N91024R00013Awarded to Pathcision Medicine, Inc.
Posted Apr 12, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00018Definitive Contract, August 5, 2025, Full and Open Competition After Exclusion of Sources, 55 offersSolicitation | NIH NCINational Institutes of Health | SBIR Concept Award for a Novel Delivery Approach to Transform Metastatic Pancreatic Cancer Treatment and PreventionNAICS 541714, PSC AN12 | $299,981 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards